Justin A Bishop1, Masato Nakaguro2,3, Rumeal D Whaley4, Kanako Ogura5, Hiroshi Imai6, Israa Laklouk3, William C Faquin3, Peter M Sadow3, Jeffrey Gagan1, Toshitaka Nagao7. 1. Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. 2. Departments of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan. 3. Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 4. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. 5. Department of Diagnostic Pathology, Juntendo University Nerima Hospital, Tokyo, Japan. 6. Pathology Division, Mie University Hospital, Tsu, Japan. 7. Department of Anatomical Pathology, Tokyo Medical University, Tokyo, Japan.
Abstract
AIMS: Salivary gland intraductal carcinoma (IDC) is a complex ductal neoplasm surrounded by a layer of myoepithelial cells. Recent insights have shown that there are three different types: intercalated duct-like, with frequent NCOA4-RET fusions; apocrine, with salivary duct carcinoma-like mutations; and mixed intercalated duct-like/apocrine, with RET fusions, including TRIM27-RET. In addition, an oncocytic IDC has been described, but it remains unclear whether it represents a fourth variant or simply oncocytic metaplasia of another IDC type. Our aim was to more completely characterize oncocytic IDC. METHODS AND RESULTS: Six IDCs with oncocytic changes were retrieved from the authors' archives, from three men and three women ranging in age from 45 to 75 years (mean, 63 years). Five arose in the parotid gland, with one in an accessory parotid gland. Four patients with follow-up were free of disease after 1-23 months. Several immunostains (S100, mammaglobin, androgen receptor, and p63/p40) and molecular tools (RNA sequencing, RET fluorescence in-situ hybridisation, BRAF V600E VE1 immunohistochemistry, and Sanger sequencing) were applied. Histologically, the tumours were variably cystic with solid intracystic nodules often difficult to recognise as intraductal. In all, tumour ducts were positive for S100 and mammaglobin, negative for androgen receptor, and completely surrounded by myoepithelial cells positive for p63/p40. Molecular analysis revealed TRIM33-RET in two of six cases, NCOA4-RET in one of six cases, and BRAF V600E in two of six cases. One case had no identifiable alterations. CONCLUSIONS: Oncocytic IDC shares similarities with intercalated duct-like IDC. Although additional verification is needed, the oncocytic variant appears to be sufficiently unique to be now regarded as the fourth distinct subtype of IDC. Because of its indolent nature, oncocytic IDC should be distinguished from histological mimics.
AIMS: Salivary gland intraductal carcinoma (IDC) is a complex ductal neoplasm surrounded by a layer of myoepithelial cells. Recent insights have shown that there are three different types: intercalated duct-like, with frequent NCOA4-RET fusions; apocrine, with salivary duct carcinoma-like mutations; and mixed intercalated duct-like/apocrine, with RET fusions, including TRIM27-RET. In addition, an oncocytic IDC has been described, but it remains unclear whether it represents a fourth variant or simply oncocytic metaplasia of another IDC type. Our aim was to more completely characterize oncocytic IDC. METHODS AND RESULTS: Six IDCs with oncocytic changes were retrieved from the authors' archives, from three men and three women ranging in age from 45 to 75 years (mean, 63 years). Five arose in the parotid gland, with one in an accessory parotid gland. Four patients with follow-up were free of disease after 1-23 months. Several immunostains (S100, mammaglobin, androgen receptor, and p63/p40) and molecular tools (RNA sequencing, RET fluorescence in-situ hybridisation, BRAF V600E VE1 immunohistochemistry, and Sanger sequencing) were applied. Histologically, the tumours were variably cystic with solid intracystic nodules often difficult to recognise as intraductal. In all, tumour ducts were positive for S100 and mammaglobin, negative for androgen receptor, and completely surrounded by myoepithelial cells positive for p63/p40. Molecular analysis revealed TRIM33-RET in two of six cases, NCOA4-RET in one of six cases, and BRAF V600E in two of six cases. One case had no identifiable alterations. CONCLUSIONS: Oncocytic IDC shares similarities with intercalated duct-like IDC. Although additional verification is needed, the oncocytic variant appears to be sufficiently unique to be now regarded as the fourth distinct subtype of IDC. Because of its indolent nature, oncocytic IDC should be distinguished from histological mimics.
Authors: Simion I Chiosea; Lindsay Williams; Christopher C Griffith; Lester D R Thompson; Ilan Weinreb; Julie E Bauman; Alyssa Luvison; Somak Roy; Raja R Seethala; Marina N Nikiforova Journal: Am J Surg Pathol Date: 2015-06 Impact factor: 6.394
Authors: Margaret Brandwein-Gensler; Jos Hille; Beverly Y Wang; Mark Urken; Ronald Gordon; Li Juan Wang; James R M Simpson; Roderick H W Simpson; Douglas R Gnepp Journal: Am J Surg Pathol Date: 2004-08 Impact factor: 6.394
Authors: Alena Skálová; Tomas Vanecek; Emmanuelle Uro-Coste; Justin A Bishop; Ilan Weinreb; Lester D R Thompson; Stefano de Sanctis; Marco Schiavo-Lena; Jan Laco; Cécile Badoual; Thalita Santana Conceiçao; Nikola Ptáková; Martina Baněčkova; Marketa Miesbauerová; Michal Michal Journal: Am J Surg Pathol Date: 2018-11 Impact factor: 6.394
Authors: Justin A Bishop; Jeffrey Gagan; Daniel Baumhoer; Anne L McLean-Holden; Bahram R Oliai; Marta Couce; Lester D R Thompson Journal: Head Neck Pathol Date: 2019-10-11
Authors: Juan C Hernandez-Prera; Daryoush Saeed-Vafa; Amin Heidarian; Kathleen Gewandter; Kristen Otto; Bruce M Wenig Journal: Head Neck Pathol Date: 2021-08-19
Authors: Kartik Viswanathan; Peter M Sadow; Zahra Maleki; Michiya Nishino; Zubair W Baloch; Todd E Abbott; Rema Rao; William C Faquin Journal: Cancer Cytopathol Date: 2021-10-01 Impact factor: 4.264
Authors: Adam S Fisch; Israa Laklouk; Masato Nakaguro; Vânia Nosé; Lori J Wirth; Daniel G Deschler; William C Faquin; Dora Dias-Santagata; Peter M Sadow Journal: Hum Pathol Date: 2021-05-12 Impact factor: 3.526
Authors: Lisa M Rooper; Lester D R Thompson; Jeffrey Gagan; Jacqueline Siok Gek Hwang; Nyall R London; Michael W Mikula; Todd M Stevens; Justin A Bishop Journal: Mod Pathol Date: 2022-03-23 Impact factor: 8.209
Authors: Sandra N Freiberger; Muriel Brada; Christine Fritz; Sylvia Höller; Alexander Vogetseder; Milo Horcic; Michel Bihl; Michal Michal; Martin Lanzer; Martin Wartenberg; Urs Borner; Peter K Bode; Martina A Broglie; Tamara Rordorf; Grégoire B Morand; Niels J Rupp Journal: Neoplasia Date: 2021-04-18 Impact factor: 5.715
Authors: Justin Bubola; Christina M MacMillan; Elizabeth G Demicco; Rose A Chami; Catherine T-S Chung; Iona Leong; Paula Marrano; Zeynep Onkal; David Swanson; Brandon M Veremis; Ilan Weinreb; Lei Zhang; Cristina R Antonescu; Brendan C Dickson Journal: Genes Chromosomes Cancer Date: 2021-07-08 Impact factor: 4.263